PolyPid
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PolyPid and other ETFs, options, and stocks.About PYPD
PolyPid Ltd. operates as a phase 3 biopharma company. Its proprietary PLEX technology pairs with medications, enables precise delivery of drugs at effective release rates, over pre-determined durations ranging from several days to months.
CEODikla Czaczkes Akselbrad
CEODikla Czaczkes Akselbrad
Employees61
Employees61
HeadquartersPetach Tikva, HaMerkaz
HeadquartersPetach Tikva, HaMerkaz
Founded2008
Founded2008
Employees61
Employees61
PYPD Key Statistics
Market cap62.79M
Market cap62.79M
Price-Earnings ratio-1.34
Price-Earnings ratio-1.34
Dividend yield—
Dividend yield—
Average volume108.43K
Average volume108.43K
High today$4.05
High today$4.05
Low today$3.94
Low today$3.94
Open price$4.03
Open price$4.03
Volume63.96K
Volume63.96K
52 Week high$4.07
52 Week high$4.07
52 Week low$2.30
52 Week low$2.30
Stock Snapshot
With a market cap of 62.79M, PolyPid(PYPD) trades at $3.95. The stock has a price-to-earnings ratio of -1.34.
On 2025-12-16, PolyPid(PYPD) stock moved within a range of $3.94 to $4.05. With shares now at $3.95, the stock is trading +0.3% above its intraday low and -2.5% below the session's peak.
Trading volume for PolyPid(PYPD) stock has reached 63.96K, versus its average volume of 108.43K.
The stock's 52-week range extends from a low of $2.30 to a high of $4.07.
The stock's 52-week range extends from a low of $2.30 to a high of $4.07.
People also own
Based on the portfolios of people who own PYPD. This list is generated using Robinhood data, and it’s not a recommendation.